Tag archive for ‘VBL Therapeutics’
Gali Weinreb On Thursday, October 2nd, 2014

VBL Therapeutics raises $40 million in revived Nasdaq IPO

– After the fiasco of the failed IPO in August, the drug development company scaled down the offering. VBL Therapeutics has raised $40 million at a company value of $120 million in a revived IPO on Nasdaq. More...

Gali Weinreb On Sunday, August 3rd, 2014

3 Israeli biomed cos fall sharply after Nasdaq IPOs

– BioBlast’s share lost 38% of its value, Macrocure 25%, and VBL Therapeutics 18%. –   The shares of three Israeli biomedical companies that completed their IPOs last Wednesday More...

Globes On Thursday, July 31st, 2014

VBL Therapeutics prices Nasdaq IPO

– The clinical stage biotech company is selling 5.4 million ordinary shares at $12 each. Clinical-stage biotech company VBL Therapeutics has announced the pricing of its Nasdaq IPO. The company is selling More...

Michael Ordman On Sunday, December 22nd, 2013

Good News From Israel No. 12 : Business, Science, Technology And More

– In the 22nd Dec 2013 edition of Israel’s good news:   ECONOMY & BUSINESS Inflation falls by 0.4 per cent.  An 8.1% drop in the prices of fresh vegetables means that Israel’s annual inflation More...

Wordpress site Developed by Fixing WordPress Problems